An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breas ...

Medically reviewed by Adam M. Brufsky, MD, PhD The exact cause or causes of triple-negative breast cancer are unknown, but ...

A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer ...

A McGregor woman, who survived a tough battle with breast cancer, is sharing her journey to emphasize the importance of ...

University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

Researchers say the results mark the first time a vaccine - known as a neoantigen DNA vaccine - has shown such positive ...

University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit ...

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...